Abstract
A novel polymeric micelle formulation of paclitaxel (PTX) has been prepared with the purpose of improving in vitro release as well as prolonging the blood circulation time of PTX in comparison to a current PTX formulation, Taxol injection. This work was designed to investigate the preparation, in vitro release, in vivo pharmacokinetics and tissue distribution of PTX-loaded Pluronic P105 micellar system. The micelles were prepared by thin-film method using a nonionic surfactant Pluronic P105 and a hydrophobic anticancer drug, PTX. With a dynamic light scattering sizer and a transmission electron microscopy, it was shown that the PTX-loaded micelles had a mean size of approximately 24 nm with narrow size distribution and a spherical shape. The in vitro release profiles indicated that the release of PTX from the micelles exhibited a sustained release behavior. A similar phenomenon was also observed in a pharmacokinetic study in rats, in which t 1/2β and AUC of the micelle formulation were 4.9 and 5.3-fold higher than that of Taxol injection. The biodistribution study in mice showed that the PTX-loaded micelles not only decreased drug uptake by liver, but also prolonged drug retention in blood and increased distribution of drug in lung, spleen and kidney. These results suggested that the P105 polymeric micelles may efficiently load, protect and retain PTX in both in vitro and in vivo environments, and could be a useful drug carrier for i.v. administration of PTX.
Similar content being viewed by others
References
Alakhov, V., Klinski, E., Li, S. M., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., and Kabanov, A., Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf B Biointerfaces, 16, 113–134 (1999).
Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., and Kabanov, A. V., Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J. Pharmacol. Exp. Ther., 304, 845–854 (2003).
Batrakova, E. V., Li, S., Li, Y. L., Alakhov, V. Y., Elmquist, W. F., and Kabanov, A. V., Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J. Control Release, 100, 389–397 (2004).
Cho, Y. W., Lee, J., Lee, S. C., Huh, K. M., and Park, K., Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J. Control Release, 97, 249–257 (2004).
Dunn, S. E., Coombes, A. G. A., Garnett, M. C., Davis, S. S., Davies, M. C., and Illum, L., In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J. Control Release, 44, 65–76 (1997).
Gaisford, S., Beezer, A. E., and Mitchell, J. C., Diode-Array UV Spectrometric Evidence for Cooperative Interactions in Binary Mixtures of Pluronics F77, F87, and F127. Langmuir, 13, 2606–2607 (1997).
Grindel, J. M., Jaworski, T., Piraner, O., Emanuele, R. M., and Balasubramanian, M., Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J. Pharm. Sci., 91, 1936–1947 (2002).
Ha, J. C., Kim, S. Y., and Lee, Y. M., Poly(ethylene oxide)-poly (propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres — I. Preparation and characterization. J. Control Release, 62, 381–392 (1999).
Han, L. M., Guo, J., Zhang, L. J., Wang, Q. S., and Fang, X. L., Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123. Acta Pharmacol Sin, 27, 747–753 (2006).
Illum, L., Jacobsen, L. O., Muller, R. H., Mak, E., and Davis, S. S., Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials, 8, 113–117 (1987).
Jones, M. C. and Leroux, J. C., Polymeric micelles — a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm, 48, 101–111 (1999).
Kabanov, A. V. and Alakhov, V. Y., Pluronic (R) block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst, 19, 1–72 (2002).
Kabanov, A. V., Batrakova, E. V., and Alakhov, V. Y., Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control Release, 82, 189–212 (2002).
Kim, S. Y. and Lee, Y. M., Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials, 22, 1697–1704 (2001).
Kumar, N., Ravikumar, M. N. V. and Domb, A. J., Biodegradable block copolymers. Adv. Drug Deliv Rev., 53, 23–44 (2001).
Lee, E. S., Na, K., and Bae, Y. H., Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control Release, 103, 405–418 (2005).
Lin, W. J., Chen, Y. C., Lin, C. C., Chen, C. F., and Chen, J. W., Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies. J. Biomed. Mater. Res. B Appl. Biomater, 77, 188–194 (2006).
Liu, H., Farrell, S., and Uhrich, K., Drug release characteristics of unimolecular polymeric micelles. J. Control Release, 68, 167–174 (2000).
Oh, K. T., Bronich, T. K., and Kabanov, A. V., Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J. Control Release, 94, 411–422 (2004).
Oku, N., Namba, Y., and Okada, S., Tumor accumulation of novel RES-avoiding liposomes. Biochim. Biophys Acta, 1126, 255–260 (1992).
Rowinsky, E. K. and Donehower, R. C., The clinical pharmacology of paclitaxel (Taxol). Semin Oncol, 20(4 Suppl 3), 16–25 (1993).
Shi, B., Fang, C., You, M. X., Zhang, Y., Fu, S. K., and Pei, Y. Y., Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice. Colloid Polym. Sci., 283, 954–967 (2005).
Wang, Y., Yu, L., Han, L., Sha, X., and Fang, X., Difunctional Pluronic copolymer micelles for paclitaxel delivery: Synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int. J. Pharm., 337, 63–73 (2007).
Yang, T., Cui, F. D., Choi, M. K., Cho, J. W., Chung, S. J., Shim, C. K., and Kim, D. D., Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int. J. Pharm., 338, 317–326 (2007).
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., and Ahmad, I., Development and characterization of a novel Cremophor (R) EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur. J. Pharm. Biopharm., 59, 177–187 (2005).
Zhang, X. C., Jackson, J. K., and Burt, H. M., Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm., 132, 195–206 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Y., Li, Y., Zhang, L. et al. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles. Arch. Pharm. Res. 31, 530–538 (2008). https://doi.org/10.1007/s12272-001-1189-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-1189-2